SPONSOR
Biocad
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 2
Conditions studied: AnemiaChronic Kidney DiseaseChronic Kidney Disease Patients on HemodialysisChronic Kidney Disease 5DTriple Negative Breast Cancer
Biocad is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis, Chronic Kidney Disease 5D.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Biocad
How many clinical trials has Biocad sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Biocad, of which 2 are actively recruiting participants. These trials cover conditions including Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Biocad research focus on?
Biocad clinical trials span Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis, Chronic Kidney Disease 5D, Triple Negative Breast Cancer. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Biocad clinical trial?
To participate in a Biocad trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Biocad trials with current recruitment status updated daily.
Clinical Trials by Biocad
NCT07119372 Phase 3
Recruiting
Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Anemia
NCT07108309 Phase 2
Recruiting
BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer
Triple Negative Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology